Spero Therapeutics Inc
NASDAQ:SPRO

Watchlist Manager
Spero Therapeutics Inc Logo
Spero Therapeutics Inc
NASDAQ:SPRO
Watchlist
Price: 0.9551 USD -4.3% Market Closed
Market Cap: 52.1m USD
Have any thoughts about
Spero Therapeutics Inc?
Write Note

Wall Street
Price Targets

SPRO Price Targets Summary
Spero Therapeutics Inc

Wall Street analysts forecast SPRO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRO is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.

Lowest
Price Target
5.05 USD
429% Upside
Average
Price Target
5.1 USD
434% Upside
Highest
Price Target
5.25 USD
450% Upside
Spero Therapeutics Inc Competitors:
Price Targets
ORY
Oryzon Genomics SA
306% Upside
6955
Shandong Boan Biotechnology Co Ltd
31% Upside
FHTX
Foghorn Therapeutics Inc.
218% Upside
IPSC
Century Therapeutics Inc
796% Upside
ALGS
Aligos Therapeutics Inc
73% Upside
377740
BioNote Inc
20% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
68% Upside
KRYS
Krystal Biotech Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Spero Therapeutics Inc

For the last 7 years the compound annual growth rate for Spero Therapeutics Inc's revenue is 126%. The projected CAGR for the next 4 years is -23%.

126%
Past Growth
-23%
Estimated Growth
Estimates Accuracy
29%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Spero Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Spero Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPRO's stock price target?
Price Target
5.1 USD

According to Wall Street analysts, the average 1-year price target for SPRO is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.

What is Spero Therapeutics Inc's Revenue forecast?
Projected CAGR
-23%

For the last 7 years the compound annual growth rate for Spero Therapeutics Inc's revenue is 126%. The projected CAGR for the next 4 years is -23%.

Back to Top